Mr Ben Powney

Currently an Associate Director within the Neurology Innovation Centre at Eisai, UK, with 19 years’ experience as an in vitro pharmacologist within the pharmaceutical industry (including positions at Pfizer, Glaxosmithkline and Eisai). Have led multiple preclinical drug discovery projects from inception through to candidate selection and current interests include the use of high content imaging and patient derived CNS cell systems to study the role of lysosomal dysfunction in neurodegeneration.